MFA Financial Inc (MFA-B) News

Keep $XXII on watch has 460K float, lots of other low floaters running this morning - $RELI, $PIK, $TRAW, $PHIO, $LYT, etc.

Now you can add 0.0000000001% to your chances of approval.

It shows for a worthless company.

$PHRRF Christmas Special - FDA provided preliminary responses to questions contained in the clarification only post-CRL meeting scheduled for December 2, 2024

PharmaTher has decided to cancel the meeting as the FDA preliminary responses were satisfactory and do not require further di

On the move

RAPT up 15% news and TRAW also up $13.77 + 150% TRAW up big

if we open around .70 I think $1 is a big possibility for today.

🔴🔴Whistleblower FOUND for AMC RICO Liquidity Fairies?:

*** Click on images to zoom? (if needed?) ***

https://investorshub.advfn.com/uimage/uploads/2024/12/11/taonfAMC_5X2.png

https://investorshub.advfn.com/uimage/uploads/2024/12/2/tdrmfA

edbl.................................https://stockcharts.com/h-sc/ui?s=edbl&p=W&b=5&g=0&id=p86431144783

Added TNXP !!!!!!!!!

ffie...................https://stockcharts.com/h-sc/ui?s=ffie&p=W&b=5&g=0&id=p86431144783

.59 + 25%

If it was happening it would be easy to find proof because the company would have disclosed it.

6.53 +'190%

Here comes the Volume- Boom Time $$$$

https://www.anavex.com/post/blarcamesine-receives-ema-filing-acceptance-for-treatment-of-alzheimer-s-disease

6.24 +170%

GMER has the stock to offer a prosperous gaming company with an acquisition or merger. Correct me if i’m wtong, but isn’t that what Dorwit has suggested he wants to happen?

CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update

GM FOLKSSSS

laes...................................https://stockcharts.com/h-sc/ui?s=laes&p=W&b=5&g=0&id=p86431144783

Blarcamesine Receives EMA Filing Acceptance for Treatment of Alzheimer’s Disease
GLOBENEWSWIRE 7:00 AM ET 12/23/2024
Symbol Last Price Change
AVXL 8.63down 0 (0%)
QUOTES AS OF 04:00:00 PM ET 12/20/2024
Blarcamesine: Potential novel oral treatment to target ups

5.63 +'150%